검색결과 : 4건
| No. | Article |
|---|---|
| 1 |
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas (vol 550, pg 133, 2017) Lu HZ, Liu SJ, Zhang G, Wu B, Zhu YY, Frederick DT, Hu Y, Zhong WQ, Randell S, Sadek N, Zhang W, Chen G, Cheng CR, Zeng JW, Wu LW, Zhang J, Liu XM, Xu W, Krepler C, Sproesser K, Xiao M, Miao BC, Liu JL, Song CD, Liu JY, Karakousis GC, Schuchter LM, Lu YL, Mills G, Cong YS, Chernoff J, Guo J, Boland GM, Sullivan RJ, Wei Z, Field J, Amaravadi RK, Flaherty KT, Herlyn M, Xu XW, Guo W Nature, 565(7738), E4, 2019 |
| 2 |
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance (vol 546, pg 431, 2017) Shaffer SM, Dunagin MC, Torborg SR, Torre EA, Emert B, Krepler C, Beqiri M, Sproesser K, Brafford PA, Xiao M, Eggan E, Anastopoulos IN, Vargas-Garcia CA, Singh A, Nathanson KL, Erlyn MH, Raj A Nature, 555(7695), 274, 2018 |
| 3 |
Rare cell variability and drug- induced reprogramming as a mode of cancer drug resistance Shaffer SM, Dunagin MC, Torborg SR, Torre EA, Emert B, Krepler C, Beqiri M, Sproesser K, Brafford PA, Xiao M, Ggan EE, Anastopoulos IN, Vargas-Garcia CA, Singh A, Nathanson KL, Herlyn M, Raj A Nature, 546(7658), 431, 2017 |
| 4 |
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas Lu HZ, Liu SJ, Zhang G, Wu B, Zhu YY, Frederick DT, Hu Y, Zhong WQ, Randell S, Sadek N, Zhang W, Chen G, Cheng CR, Zeng JW, Wu LW, Zhang J, Liu XM, Xu W, Krepler C, Sproesser K, Xiao M, Miao BC, Liu JL, Song CD, Liu JY, Karakousis GC, Schuchter LM, Lu YL, Mills G, Cong YS, Chernoff J, Guo J, Boland GM, Sullivan RJ, Wei Z, Field J, Amaravadi RK, Flaherty KT, Herlyn M, Xu XW, Guo W Nature, 550(7674), 133, 2017 |